Latest News

View allAccessAL amyloidosisCAR-TConferencesMPEMyelomaNewsPatient evidenceSin categoríaVideos

Myeloma Patients Europe (MPE) joins project consortium looking at the role of innovative CAR-T immunotherapy in multiple myeloma

Today marks the official launch of a new international project consortium, known as “CARAMBA”, which will research an innovative immunotherapy for the treatment of multiple myeloma, known as Chimeric Antigen Receptor T-cell therapy (CAR-T). Through strategic collaboration with a wide-range of stakeholders, the consortium aims to ensure the streamlined transition of CAR-T from the laboratory…

Read more

MPE will hold a webinar on ASH 2017 highlights in myeloma

Myeloma Patients Europe will hold an online webinar to review the most recent myeloma findings presented at the annual meeting of the American Society of Hematology (ASH) that took place in San Diego (California, United States) in December 2017. The talk will be given by Dr María Victoria Mateos, Associate Professor of Hematology and Consultant.…

Read more

ASH Annual Meeting 2017 is about to start

The 59th American Society of Hematology (ASH) Annual Meeting will take place from 9 – 12 December in Atlanta, Georgia, United States (US). Myeloma Patients Europe (MPE) will be attending the meeting, alongside thousands of leading doctors, researchers and patient advocates in the field of blood cancer (hematology). Below we explain ASH and the importance…

Read more

Promising results of CAR T-Cell therapy in myeloma patients

53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) CHICAGO – In an early clinical trial, 33 out of 35 (94%) patients had clinical remission of myeloma upon receiving a new type of immunotherapy  ̶  chimeric antigen receptor (CAR) T cells targeting B-cell maturation protein or BCMA. Most patients had only mild side effects. The study was presented at the 2017 American Society of Clinical Oncology (ASCO) Annual…

Read more

Patients and cancer experts launch a joint vision for improving cancer outcomes in Europe

A coalition of 60 patient advocates, healthcare professionals and scientists (including 3 Nobel Prize winners) from 20 European countries have come together to publish a blueprint for improving cancer outcomes and achieving better quality of life for cancer survivors throughout Europe.1 They are members of the European Cancer Concord (ECC®), an equal partnership between patients…

Read more
August

September 2026

October
MO
TU
WE
TH
FR
SA
SU
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
1
2
3
4
Events for 1st September
No Events
Events for 2nd September
No Events
Events for 3rd September
No Events
Events for 4th September
No Events
Events for 5th September
No Events
Events for 6th September
No Events
Events for 7th September
No Events
Events for 8th September
No Events
Events for 9th September
No Events
Events for 10th September
No Events
Events for 11th September
No Events
Events for 12th September
No Events
Events for 13th September
No Events
Events for 14th September
No Events
Events for 15th September
No Events
Events for 16th September
No Events
Events for 17th September
No Events
Events for 18th September
No Events
Events for 19th September
No Events
Events for 20th September
No Events
Events for 21st September
No Events
Events for 22nd September
No Events
Events for 23rd September
No Events
Events for 24th September
No Events
Events for 25th September
No Events
Events for 26th September
No Events
Events for 27th September
No Events
Events for 28th September
No Events
Events for 29th September
No Events
Events for 30th September
No Events